Major Advance In Treatment Of Multiple Myeloma

Mayo Clinic Cancer Center announced that a multiple myeloma clinical trial has shown a significant improvement in survival with lenalidomide plus low-dose dexamethasone therapy compared to lenalidomide plus high-dose dexamethasone. The study led by the Eastern Cooperative Oncology Group (ECOG) and supported by the National Cancer Institute compared combination treatment of oral medications lenalidomide and either high- or low-dose dexamethasone in 445 patients with newly-diagnosed myeloma. Lenalidomide plus high-dose dexamethasone had a one-year survival rate of 86 percent. The comparative therapy using low-dose... Whole article: "http://www.sciencedaily.com":[ http://www.sciencedaily.com/releases/2007/04/070404174310.htm]

---

Related articles

Mayo Clinic Study Shows Drug-Eluting Stent Use in Heart Patients Determined More by Insurance Type, Hospital Location than Medical Condition - If you want the best technology available to relieve blocked blood flow to the heart, the choice is a drug-eluting stent (28.3.2007)

Irregular Heartbeat Linked to Genetic Mutation, Mayo Clinic Study Shows - Every day for 10 years, a seemingly heart-healthy 53-year-old woman experienced rapid and irregular heartbeats (27.2.2007)

Mayo Discovers Protein as Potential Tactic to Prevent Tumors - The researchers examined a protein called cyclin-dependent kinase 2 (CDK2), which works as a "quality control inspector (5.11.2006)

Mayo Researchers Discover HIV Dependence On A Human Protein - Mayo Clinic virologists have discovered that a specific human protein is essential for HIV to integrate into the human genome (20.9.2006)

Mayo Clinic (only in Czech language) - Americká Mayo Clinic z Rochesteru, jedna z nejlepších univerzitních nemocnic USA a současně nositelka Nobelovy ceny za medicínu, se bude aktivně účastnit projektu Mezinárodního centra klinického výzkumu (International Clinical Research Center Brno, dále jen ICRC), které vzniká při Fakultní nemocnici u sv (18.4.2006)